Proprotein convertases in high-density lipoprotein metabolism.

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Science

Background:

• Proprotein convertase subtilisin/kexins (PCSKs) are serine endopeptidases involved in precursor protein modulation.
• Genetic alterations in PCSKs are linked to metabolic processes and cardiovascular disease.
• High-density lipoprotein (HDL) plays a crucial role in cholesterol removal and preventing atherosclerosis.

Purpose of the Study:

• To review the roles of five PCSK members (PCSK1, PCSK3, PCSK5, PCSK6, PCSK9) in lipid, glucose, and bile acid metabolism.
• To explore the influence of PCSKs on high-density lipoprotein (HDL) metabolism and reverse cholesterol transport.
• To propose an integrative model of PCSK-mediated regulation of HDL metabolism.

Main Methods:

• Literature review summarizing existing research on PCSKs and metabolic processes.
• Analysis of evidence from patient and animal models with genetic alterations in PCSKs.
• Synthesis of findings to propose a regulatory model for HDL metabolism.

Main Results:

• PCSK3, PCSK5, and PCSK6 process key lipases (endothelial lipase, lipoprotein lipase) involved in HDL remodeling.
• PCSK1 alterations increased serum apolipoprotein A1 (APOA1) levels in mouse models.
• PCSK9 deficiency decreased APOE-containing HDL in mouse models.
• Genetic variations in PCSKs may affect the efficiency of reverse cholesterol transport.

Conclusions:

• PCSK members play significant roles in regulating HDL metabolism through diverse molecular and metabolic pathways.
• PCSKs are promising therapeutic targets for cardiovascular diseases.
• Further understanding of PCSK functions can enhance therapeutic strategies and drug efficacy while minimizing adverse effects.